ARCHIVES

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

This article is from The Cancer Letter archive.

Vol. 13 No. 23 | June 5, 1987

Download PDF Visit The Full Archive

Related Articles

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

Hatch Introduces Bill to Modify Delaney Amendment

June 13, 1986

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

NCI Sponsors Session At ASCO On Clinical Grant Applications

May 3, 1991

Fewer Young Scientists win NIH Grants, Study

September 30, 1994

Barnett Kramer Retires From NIH

January 7, 2011